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Abstract
The objective of this book chapter is to provide consolidated and updated 
scientific information about the medicinal plants of the Peruvian Amazon, which 
has a great richness of plants; many of these are used in folkloric medicine to 
treat several diseases. Recently, investigations have reported that these medicinal 
plants possess bioactive phytochemicals against several diseases such as diabetes, 
cancer, inflammation, infectious diseases, and several other health problems, thus 
corroborating some ethnopharmacological reports. The mechanism of action for 
selected bioactive phytochemicals was demonstrated at the molecular level as well 
as the metabolic pathways involved in their biosynthesis were described. Due to the 
large gap in scientific information revealed in this review, we formulated a series of 
strategies to close these scientific knowledge gaps and achieve a sustainable exploi-
tation of medicinal plants in the Peruvian Amazon.
Keywords: cancer, diabetes, ethnopharmacological survey, folkloric medicine
1. Introduction
Peru is cataloged as a megadiverse country due to its great diversity of species, 
particularly in plants [1, 2]. This diversity is attributed to the large number of 
eco-regions present in our territory [3], which were originated by their particular 
geologic evolution [4]. The Peruvian Amazon includes a large proportion of this 
richness in plant species, and several are endemic to this region [5, 6]. The diversity, 
however, remains underestimated because until now a complete and updated inven-
tory of plant species is lacking, but some estimates suggest that more than 50% of 
plant species are unknown to science [7, 8].
Pharmacognosy - Medicinal Plants
2
Similarly, there are many gaps in the scientific knowledge of medicinal plants 
of the Peruvian Amazon. These gaps are evident at various knowledge levels from 
the inventory of medicinal plants and their taxonomic identification, the bioactive 
phytochemicals produced, the mechanisms of action of the bioactive phytochemi-
cals, and the metabolic pathways involved in the biosynthesis of bioactive phyto-
chemicals. In part, these gaps in the scientific knowledge can be attributed to several 
factors: (1) the ethnopharmaceutical information has been obtained from few ethnic 
groups (probably <10%); (2) the majority of ethnopharmaceutical surveys have 
been focused on plant species to treat protozoal diseases, with particular emphasis 
on malaria and leishmania [9–12]; and (3) the research centers in the Peruvian 
Amazon generally lack trained scientist, laboratory equipment, and standard 
methods to perform bioassays for the discovery of bioactive phytochemicals against 
diabetes, inflammation, hypertension, cancer, infectious diseases (viral, bacterial, 
and fungal), and other health problems. Consequently, it is fundamental to imple-
ment strategies to surpass these limitations and to close these large knowledge gaps.
Parts of the problems mentioned are addressed in this book chapter that 
consists of six topics. The first topic “The diversity of plants in the Peruvian 
Amazon” describes the diversity of species reported for the country and the 
Peruvian Amazon and are mentioned the possible factors involved in light of 
current knowledge. The second topic “Medicinal plants and indigenous people 
in the Peruvian Amazon” highlights information about medicinal plants and 
ethnic groups. Relevant information of the recently elaborated partial database of 
medicinal plants is also discussed. The third topic “Some bioactive phytochemicals 
identified in medicinal plants” presents structures of bioactive phytochemicals 
against cancer, inflammation, diarrhea, malaria, and diabetes. The fourth topic 
“Mechanism of action of select bioactive phytochemicals” explains the molecular 
bases of the mechanisms of action of well-characterized phytochemicals such 
as taspine, crofelemer, mitraphylline, quercetin, linalool, and bixin. The fifth 
topic “Biosynthetic pathways for relevant bioactive phytochemicals” describes 
and provides graphically key metabolic pathways involved in the biosynthesis 
of quercetin, linalool, and bixin. The final topic “Strategies for the sustainable 
use of medicinal plants” recommends the adoption of strategies to accelerate the 
generation of scientific knowledge that permits a sustainable exploitation of the 
medicinal plants in the Peruvian Amazon.
2. The diversity of plants in the Peruvian Amazon
The plant diversity in the Amazonian lowland rain forest is astounding. This 
diversity was recently demonstrated with a large-scale taxonomic inventory, 
which identified 14,003 species; 1788 genera; and 188 families of seed plants, 
in which 50% of these species can reach ≥10 cm stem diameter at breast height 
(DBH). More than 52% of seed plant species diversity in this region include 
shrubs, small trees, lianas, vines, and herbs [1]. The Peruvian Amazon includes 
~39% (5401 species) of these species. Also, a previous study showed that a forest 
near to Iquitos is the most species-rich in the world, with ~300 species ≥10 cm in 
DBH [2]. In addition, it is estimated that ~17,143 plant species are circumscribed 
within the national boundaries [13], and approximately 13% of these plant spe-
cies are endemic to the Peruvian Amazon [5, 6]. It is speculated, however, that 
only 60% of the Peruvian flora has been identified [7]. Consequently, Peru is 
considered to be one of the 17 megadiverse countries, a global center for species 
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richness of plants and other organisms [14]. This peculiarity is attributed to the 
most Holdridge life zones (containing 84 of the 107 eco-regions of the world) 
that possess our country [3], which was determined for their particular geologic 
evolution [4].
3. Medicinal plants and indigenous people in the Peruvian Amazon
The Amazon lowland rain forest provides multiple benefits to its inhabitants 
[15]. According to Schultes [16], rain forests have an incalculable value as an 
untapped emporium of germplasm for new commercial plants. For example, to 
the inhabitants of Mishana (a community near Iquitos), the tropical forest pro-
vides timber resources (e.g., sawlogs and pulpwood) and several forest products 
such as edible fruits, oils, latex, fiber, and medicines. The yield of these forest 
products is provided by 72 species (26.2%) that are sold in the Iquitos market 
[17]. In addition, it is estimated that ~4400 native plant species of the Peruvian 
flora are used by inhabitants for 49 different applications [18]. With reference to 
bioactive plants, it was reported that more than 1300 species are used by natives 
in the northwest Amazon as medicines, poisons, or narcotics [16]. To date, 
however, the list of medicinal plants useful for the discovery and development 
Figure 1. 
Families of medicinal plants (A) and number of their uses (B) to treat diseases in the Peruvian Amazon.
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of drugs is fragmentary and incomplete, because the ethnopharmacological 
surveys conducted in the Peruvian Amazon are sporadic and scarce. Recently, 
we elaborated a partial database of medicinal plants of the Peruvian Amazon, 
which is based on the few available ethnobotanical studies [9–12, 19–25], one list 
of the Research Institute of The Peruvian Amazon (IIAP) and surveys carried 
out by our research group in the Pasaje Paquito (the main center for commercial-
ization of medicinal plants in the Loreto region, Iquitos). The medicinal plant 
database includes 1410 species belonging to 157 plant families; these taxonomic 
assignations were verified with the Plant List database (http://www.theplantlist.
org/). Of these, the top 10 families by number of medicinal plant species are 
Fabaceae (137), Asteraceae (80), Rubiaceae (57), Araceae (53), Piperaceae (51), 
Solanaceae (51), Euphorbiaceae (47), Apocynaceae (39), Bignoniaceae (39), and 
Clusiaceae (32). In addition, this database reveals that the plant families with 
the highest number of medicinal uses are Fabaceae (272), Asteraceae (244), 
Rubiaceae (197), Euphorbiaceae (180), Piperaceae (179), and Solanaceae with 
166 medicinal uses (Figure 1).
It is paradoxical that only some ethnic groups were evaluated to date for ethno-
pharmacological surveys, given the Peruvian Amazon’s ethnic diversity (Figure 2). 
According to a recent national census, the indigenous population of the Peruvian 
Amazon consists of 332,975 inhabitants that include 13 linguistic families that are 
grouped into 51 ethnic groups. Of the total number of communities registered, 
21 are polyethnic [26, 27]. In all these ethnic groups, the millenary knowledge of 
medicinal plants used to combat common diseases is a fundamental component 
within the indigenous health systems, which has been maintained from generation 
to generation. However, due to the transculturation by modernization and global-
ization, this ancestral knowledge is being lost [15]. Consequently, it is necessary 
to implement strategies to preserve this invaluable knowledge for the benefit of 
humankind.
4. Some bioactive phytochemicals identified in medicinal plants
Presently, the list of medicinal plants of the Peruvian Amazon is partial; in 
consequence, only for the most known plants were identified a few bioactive 
phytochemicals (Figure 3). There is no way to estimate how many new biochemi-
cal structures, probably of great value to humankind, remain undiscovered in the 
Peruvian Amazon. Some of the phytochemicals isolated and with corroborated 
bioactivity against cancer [28], inflammation [29], diarrhea [30], malaria [31], 
diabetes [32], and several other diseases were determined [33].
Figure 2. 
Selected ethnic groups from the Peruvian Amazon.
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5. Mechanism of action of select bioactive phytochemicals
5.1 Bixin
Bixin constitutes the main pigment of the industrial annatto obtained from the 
seed coat of Bixa orellana [34]. This phytochemical belongs to the relatively small fam-
ily of apocarotenoids; it was the first cis-carotenoid to be isolated from natural sources 
[35]. However, it was not until 1961 that its chemical structure and stereochemistry 
were determined through nuclear magnetic resonance spectroscopy studies [36].
This phytochemical compound shows pleiotropic bioactivities with health-
promoting properties. It was recently demonstrated that bixin caused arrest of 
Hep3B cell line at G2/M checkpoint of the cell cycle and the molecular mechanism 
of action was demonstrated by a modeling study, which was based in the favorable 
Figure 3. 
A small selection of bioactive phytochemicals identified in medicinal plants of the Peruvian Amazon.
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binding of bixin to domains of Bax BH3 and FasL proteins [37]. Consequently, 
bixin should be used for developing agents to combat human hepatocellular car-
cinoma. Bixin is also a potent activator of the transcription factor nuclear factor 
erythroid 2-related factor 2 (NRF2), which is the master regulator of the cellular 
antioxidant response protecting the skin against various environmental stressors 
including UV radiation and electrophilic pollutants [38–40]. The protective effects 
against solar UV-induced skin damage are due to the NRF2-dependence of bixin-
induced antioxidant and anti-inflammatory effects [39]. In addition, bixin displays 
molecular activities as antioxidant, excited-state quencher, peroxisome proliferator-
activated receptor α/γ agonist, and Toll-like receptor 4/nuclear factor kappa-light-
chain-enhancer of activated B-cell antagonist. Together, these bioactivities may be 
important to the improvement of skin barrier function and environmental stress 
protection [40].
5.2 Crofelemer
Crofelemer previously known as SP-303 is a large proanthocyanidin oligomer 
isolated from the bark latex of the plant Croton lechleri Müll. Arg. [41]. Initial 
studies have demonstrated the immense antiviral activity of crofelemer against 
a gamma of DNA and RNA viruses such as respiratory syncytial virus, influenza 
A virus, parainfluenza virus, herpesvirus types 1 and 2, and hepatitis A and B 
viruses. The antiviral mechanism implies the direct interaction of crofelemer to 
components of the viral envelope, blocking both the viral attachment and the cell 
invasion [41]. More recently, crofelemer is used as a first-in-class antidiarrheal 
medication, and its efficacy has been investigated in vivo assays [42] and in patients 
with HIV-associated diarrhea, diarrhea of various infectious etiologies, as well as 
diarrhea-predominant irritable bowel syndrome [43]. Crofelemer was recently 
approved by the FDA to treat diarrhea in HIV/AIDS patients on antiretroviral 
therapy [44].
The mechanism of action as antidiarrheal of this proanthocyanidin oligomer 
consists in the dual inhibitory action on two structurally unrelated prosecretory 
intestinal Cl− channels, which are responsible for chloride secretion and subse-
quent luminal hydration. The first target is an extracellular site of the cystic fibrosis 
transmembrane regulator (CFTR) Cl− channel (∼60%, IC50 ∼ 7 μM), which 
produces a voltage-independent block with stabilization of the channel closed state. 
The second target is the intestinal calcium-activated Cl− channel (CaCC) by a 
voltage-independent inhibition mechanism (>90%, IC50 ∼ 6.5 μM) [45].
5.3 Linalool
An abundant (~90%) essential oil of the leaves of Aniba rosaeodora [46, 47] that is 
used in the traditional medicine of the Peruvian and Brazilian Amazon for its effects 
on the central nervous system, such as sedative, anticonvulsant, and antidepressant 
[19, 47, 48]. Additionally, linalool has anti-inflammatory [49], anticancer [50–52], 
antihyperlipidemic, antinociceptive, analgesic, anxiolytic, and neuroprotective 
properties [53]. Several studies have demonstrated a gamma of anti-infectious activity 
like antiviral [54], antibacterial [55–57], antifungal [58, 59], and antileishmanial [55, 
60, 61].
The anticancer mechanisms of action of linalool in hepatocellular carcinoma 
(HCC) HepG2 cells were recently revealed by Rodenak-Kladniew et al. [50] 
(Figure 4). According to these researchers,  linalool in a dose-dependently blocked 
cell proliferation by inducing G0/G1 cell cycle arrest, through Cdk4 and cyclin 
A downregulation, p21 and p27 upregulation, and apoptosis, characterized by 
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mitochondrial membrane potential loss, caspase-3 activation, poly(ADP-ribose) 
polymerase cleavage, and DNA fragmentation
5.4 Mitraphylline
A pentacyclic oxindolic alkaloid that was isolated from the alkaloid fraction of 
the dried inner bark of Uncaria tomentosa (Willd. ex Schult.) DC; it represents the 
most abundant phytochemical (40%) of the alkaloid fraction [62]. Several investi-
gations have demonstrated the immunoregulatory activity of this compound or the 
pentacyclic oxindolic alkaloid-enriched fraction [63–67].
The mechanism of action as immunoregulator of mitraphylline consists in 
both to protect cells against oxidative stress and to elicit a response via an NF-kβ-
dependent mechanism. The first mechanism is based on the inhibition of the 
inducible nitric oxide synthase gene expression; consequently, nitrite formation 
and programmed cell death are avoided. Finally, in the second mechanism, the 
inhibition of NF-kβ signaling permits the abrogation of the release of pro-inflam-
matory cytokines such as TNFα, IL-6, IL-1 α, IL-1β, IL-4, IL-17, and IFN-α [63–67].
5.5 Quercetin
A polyphenol categorized as a flavonol, one of the five subclasses of flavonoid 
compounds. This bioactive phytochemical is biosynthesized and accumulated in 
Figure 4. 
Anticancer mechanisms of action of linalool in hepatocellular carcinoma (HCC) HepG2 cells.
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tissues and organs of several medicinal plants of the Peruvian Amazon such as 
Annona montana, Bauhinia longifolia, Bertholletia excelsa, Genipa americana, Inga 
edulis, Mauritia flexuosa, Myrciaria dubia, Oenocarpus bataua, Solanum sessiliflorum, 
Theobroma bicolor, T. cacao, and T. grandiflorum [68–70]. Quercetin exhibits mul-
tifaceted therapeutic applications for multiplicity of unrelated acute and chronic 
human ailments like allergy, arthritis, asthma, bacterial and viral infections, cancer, 
cardiovascular diseases, inflammation, obesity, diabetes, mood disorders, neuropa-
thologies, and other health problems [71–76].
This multiple health beneficial properties of quercetin are attributed to their 
particular mechanism of action based on inhibition of several key proteins and 
enzymes (Figure 5). For example, a recent research showed that this compound is a 
potent inhibitor of 25 human serine/threonine kinases [77]. The multitarget inhibitor 
explains its beneficial pleiotropic effects on humans. This flavonoid-type inhibitor is 
effective against xanthine oxidase, appropriate for the treatment of hyperuricemia, 
gout, and inflammatory disease states. The inhibitory mechanism is based on the 
favorable steric complementarity of the conjugated three-ring structure of quercetin 
with the active site of xanthine oxidase. The enzyme-quercetin binary complex is 
stabilized by van der Waals forces and hydrogen-bonding interactions with both  
binding and catalytic amino acid residues, respectively [78, 79]. Recently, Hamilton  
et al. [80] have demonstrated that quercetin is a competitive inhibitor of glucose 
uptake by GLUT1. These researchers showed that the inhibitory effect is simply by 
binding of quercetin to the surface of GLUT1 [80]. Finally, several structural stud-
ies by X-ray diffraction have corroborated the inhibitory complex of quercetin with 
several human protein kinases [81–83].
5.6 Taspine
An alkaloid isolated for the first time by Vaisberg et al. [84] from the bark latex 
of the plant species Croton lechleri Müll. Arg. Previous in vitro and in vivo investiga-
tions have demonstrated that taspine promotes early phases of wound healing in 
a dose-dependent manner [84, 85]. Taspine was also demonstrated to activate the 
pro-apoptotic cascade, which oligomerizes Bak/Bax into pores that result in the 
release of cytochrome c and consequently apoptosis in HCT116 colon carcinoma 
cells [86]. Similar results were reported for an in vivo study conducted with ZR-75-
30 human breast cancer xenografts in athymic mice [87].
The mechanism of action of taspine as a topoisomerase inhibitor was revealed 
recently. Initially, using in vitro assays, Fayad et al. [86] observed the inhibition 
of both topoisomerases I and II by taspine. Castelli et al. [88] corroborated the 
Figure 5. 
Inhibitory complex of quercetin with selected human kinase targets.
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inhibitory action of taspine on purified topoisomerase I and provided the molecular 
details of the inhibitory action. These researchers showed that taspine inhibits the 
catalytic process (cleavage and religation), and molecular docking simulations 
showed that the formation of the complex enzyme-taspine is accomplished by 
the interaction in the proximity of the active site preventing the cleavage reac-
tion. While, that the religation inhibition is explained by DNA intercalation of the 
inhibitor with the enzyme-DNA-binary complex.
6. Biosynthetic pathways for relevant bioactive phytochemicals
6.1 Bixin biosynthesis
The biosynthesis of the apocarotenoid ester bixin from lycopene requires four 
enzymatic reactions (Figure 6). The first enzymatic reaction of bixin biosynthesis 
is the 5-6/5′-6′ oxidative cleavage of lycopene catalyzed by lycopene cleavage 
oxygenase to produce two sulcatone and one bixin aldehyde molecule. The second 
enzymatic reaction is the oxidative conversion of aldehyde into carboxylic acid 
groups in bixin aldehyde to produce norbixin by bixin aldehyde dehydrogenase. 
The third enzymatic reaction is the methylation of one norbixin carboxyl group 
to produce bixin by norbixin methyltransferase. This enzyme utilizes S-adenosyl-
l-methionine as a methyl-group donor. Finally, the last biochemical reaction is 
the methylation of one bixin carboxyl group to produce bixin dimethyl ester by 
bixin methyltransferase, using S-adenosyl-l-methionine as methyl-group donor 
[89–91].
6.2 Linalool biosynthesis
The fundamental building blocks in plants for terpenoid production, i.e., 
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), are 
generated via two independent pathways, namely, 2-C-methyl-d-erythritol 
4-phosphate (MEP) pathway and the mevalonate acid (MVA) pathway [92, 93]. 
The plastid terpenes are formed exclusively via the MEP pathway; however, sterols 
are biosynthesized via MVA pathway in the cytoplasm and mitochondria [94, 95]. 
Radiolabeling studies in the early 1970s showed that in Cinnamomum camphora the 
biosynthesis of linalool is accomplished via the MVA pathway [96]. Nevertheless, 
recent transcriptome analysis of leaves in two chemotypes of C. camphora showed 
that both pathways provide the biosynthetic precursors IPP and DMAPP for the 
main monoterpenes (i.e., linalool and borneol) synthesis [97]. The balance of IPP/
DMAPP is controlled by type 1 and type 2 isopentenyl diphosphate:dimethylallyl 
diphosphate isomerase, which reversibly converts IPP to DMAPP [98, 99]. Further, 
IPP and DMAPP are condensed by geranyl diphosphate synthase and isopentenyl 
diphosphate to produce geranyl diphosphate by geranyl diphosphate synthase. 
Finally, geranyl diphosphate is transformed in linalool by the action of linalool 
synthase (Figure 7).
6.3 Quercetin biosynthesis
A bioactive phytochemical that is biosynthesized through the phenylpropanoid 
pathway [100]. The initial reactions transform phenylalanine into 4-coumaroyl-
CoA, which enters into the flavonoid biosynthesis pathway (Figure 8). The first 
committed enzyme in the flavonoid pathway, chalcone synthase, uses malonyl-CoA 
and 4-coumaroyl-CoA as substrates to produce naringenin chalcone. This metabolic 
Pharmacognosy - Medicinal Plants
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intermediary is converted to (+)-dihydrokaempferol by the action of two enzymes, 
one isomerase and one dioxygenase, respectively. Next, (+)-dihydrokaempferol 
quercetin is biosynthesized by two alternative and consecutive enzymatic reac-
tions: first, enzymes (+)-dihydrokaempferol 3′-hydroxylase and quercetin synthase 
produce (+)-taxifolin as a metabolic intermediary, and, second, enzymes dihy-
drokaempferol synthase and kaempferol monooxygenase produce kaempferol as a 
metabolic intermediary [101].
Figure 6. 
Biosynthetic pathway for bixin.
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7. Strategies for the sustainable use of medicinal plants
To date, the research contributions of the Peruvian Amazon to ethnophar-
macology have been very limited, and data are still fragmentary and dispersed. 
Consequently, to ensure a sustainable economic development, we need to obtain 
a competitive advantage based on our medicinal plant resources. To achieve these 
goals, we must formulate appropriate strategies based on solid scientific knowledge. 
First, we need to record the millenary knowledge of folk medicine practiced by the 
total ethnic groups of the Peruvian Amazon. Second, based on this information, we 
Figure 7. 
Biosynthetic pathway for linalool through the MEP pathway.
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should construct a complete catalog of known medicinal plants with correct taxo-
nomic identifications. Third, an enriched germplasm bank of medicinal plants should 
be established with accessions of several sites of the Peruvian Amazon. Fourth, 
the bioactivity of extracts/bio-guided isolated and purified phytochemicals with a 
battery of in vitro and in vivo standardized bioassays against multiple diseases (e.g., 
diabetes, cancer, bacterial infections, etc.) should be established. Fifth, multiomics 
approaches such as genomics, transcriptomics, proteomics, and metabolomics should 
be performed to identify key genes, enzymes, and metabolic pathways responsible 
for the biosynthesis of promising bioactive phytochemicals. Sixth, in the short term, 
a web-based computerized database to facilitate storage, management, transfer and 
Figure 8. 
Biosynthetic pathway for quercetin.
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exchange, and analysis of the data by researchers, planners, and other interested 
users should be developed and made freely available. Finally, the availability of this 
basic scientific information could support the development of genetic improvement 
programs for medicinal plants and allow a boost of biotechnological applications, 
based on synthetic biology tools and using bacterial, microalgal, and several other 
cell-/tissue-based platforms for the production of phytochemical compounds of 
interest, thus preventing overexploitation and species extinction of medicinal plants.
8. Conclusions
The Peruvian Amazon houses multiple medicinal plants, but the species catalog 
is still incomplete, because ethnopharmaceutical studies are lacking in the great 
majority of ethnic groups. A select number of medicinal plant species, however, 
have been identified as a potentially useful source of bioactive phytochemical 
compounds to treat various diseases such as diabetes, cancer, inflammation, and 
infections caused by pathogens, among other health problems. Also, for some of 
these bioactive phytochemical compounds, the mechanisms of action are known, 
which are characterized by presenting a common pattern, their pleiotropic effects, 
which is attributable to act on multiple targets, consequently, affecting various cel-
lular processes. In relation to the metabolic pathways responsible for biosynthesis of 
these molecules, only very few are known, but for the vast majority of phytochemi-
cals, it remains a great mystery that needs to be clarified. Therefore, we formulated 
a series of strategies to close these scientific knowledge gaps and achieve a sustain-
able exploitation of medicinal plants in the Peruvian Amazon.
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